Cargando…
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688520/ https://www.ncbi.nlm.nih.gov/pubmed/34931014 http://dx.doi.org/10.1038/s41598-021-04066-1 |
| _version_ | 1784618370293825536 |
|---|---|
| author | Moufarrij, Sara Srivastava, Aneil Gomez, Stephanie Hadley, Melissa Palmer, Erica Austin, Paul Tran Chisholm, Sarah Diab, Noor Roche, Kyle Yu, Angela Li, Jing Zhu, Wenge Lopez-Acevedo, Micael Villagra, Alejandro Chiappinelli, Katherine B. |
| author_facet | Moufarrij, Sara Srivastava, Aneil Gomez, Stephanie Hadley, Melissa Palmer, Erica Austin, Paul Tran Chisholm, Sarah Diab, Noor Roche, Kyle Yu, Angela Li, Jing Zhu, Wenge Lopez-Acevedo, Micael Villagra, Alejandro Chiappinelli, Katherine B. |
| author_sort | Moufarrij, Sara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8688520 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86885202021-12-22 Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer Moufarrij, Sara Srivastava, Aneil Gomez, Stephanie Hadley, Melissa Palmer, Erica Austin, Paul Tran Chisholm, Sarah Diab, Noor Roche, Kyle Yu, Angela Li, Jing Zhu, Wenge Lopez-Acevedo, Micael Villagra, Alejandro Chiappinelli, Katherine B. Sci Rep Author Correction Nature Publishing Group UK 2021-12-20 /pmc/articles/PMC8688520/ /pubmed/34931014 http://dx.doi.org/10.1038/s41598-021-04066-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Moufarrij, Sara Srivastava, Aneil Gomez, Stephanie Hadley, Melissa Palmer, Erica Austin, Paul Tran Chisholm, Sarah Diab, Noor Roche, Kyle Yu, Angela Li, Jing Zhu, Wenge Lopez-Acevedo, Micael Villagra, Alejandro Chiappinelli, Katherine B. Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| title | Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| title_full | Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| title_fullStr | Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| title_full_unstemmed | Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| title_short | Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| title_sort | author correction: combining dnmt and hdac6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688520/ https://www.ncbi.nlm.nih.gov/pubmed/34931014 http://dx.doi.org/10.1038/s41598-021-04066-1 |
| work_keys_str_mv | AT moufarrijsara authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT srivastavaaneil authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT gomezstephanie authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT hadleymelissa authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT palmererica authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT austinpaultran authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT chisholmsarah authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT diabnoor authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT rochekyle authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT yuangela authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT lijing authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT zhuwenge authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT lopezacevedomicael authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT villagraalejandro authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer AT chiappinellikatherineb authorcorrectioncombiningdnmtandhdac6inhibitorsincreasesantitumorimmunesignalinganddecreasestumorburdeninovariancancer |